These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27127282)

  • 1. Yonder: Self-harm, repeat prescribing, deprescribing, and worry.
    Rashid A
    Br J Gen Pract; 2016 May; 66(646):261. PubMed ID: 27127282
    [No Abstract]   [Full Text] [Related]  

  • 2. Motivating deprescribing conversations for patients with Alzheimer's disease and related dementias: a descriptive study.
    Antonelli MT; Cox JS; Saphirak C; Gurwitz JH; Singh S; Mazor KM
    Ther Adv Drug Saf; 2022; 13():20420986221118143. PubMed ID: 36052398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deprescribing: An educational imperative.
    Raman-Wilms L; Farrell B; Sadowski C; Austin Z
    Res Social Adm Pharm; 2019 Jun; 15(6):790-795. PubMed ID: 30241871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprescribing in older people.
    Page AT; Potter K; Clifford R; Etherton-Beer C
    Maturitas; 2016 Sep; 91():115-34. PubMed ID: 27451330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scoping review of perceptions from healthcare professionals on antipsychotic prescribing practices in acute care settings.
    Jaworska N; Moss SJ; Krewulak KD; Stelfox Z; Niven DJ; Ismail Z; Burry LD; Fiest KM
    BMC Health Serv Res; 2022 Oct; 22(1):1272. PubMed ID: 36271347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swimming Against the Tide: Primary Care Physicians' Views on Deprescribing in Everyday Practice.
    Wallis KA; Andrews A; Henderson M
    Ann Fam Med; 2017 Jul; 15(4):341-346. PubMed ID: 28694270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yonder: Obesity communication, opioid deprescribing, actinic keratosis, and artificial intelligence.
    Rashid A
    Br J Gen Pract; 2019 Jul; 69(684):350. PubMed ID: 31249088
    [No Abstract]   [Full Text] [Related]  

  • 8. Yonder: District nursing, deprescribing, psychotropic drugs, and reasonableness.
    Rashid A
    Br J Gen Pract; 2019 Feb; 69(679):78. PubMed ID: 30705005
    [No Abstract]   [Full Text] [Related]  

  • 9. Deprescribing considerations for older people in general practice.
    Quek HW; Page A; Potter K; Etherton-Beer C
    Aust J Gen Pract; 2023 Apr; 52(4):173-180. PubMed ID: 37021442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing inappropriate polypharmacy: the process of deprescribing.
    Scott IA; Hilmer SN; Reeve E; Potter K; Le Couteur D; Rigby D; Gnjidic D; Del Mar CB; Roughead EE; Page A; Jansen J; Martin JH
    JAMA Intern Med; 2015 May; 175(5):827-34. PubMed ID: 25798731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary care physicians' approaches to low-value prescribing in older adults: a qualitative study.
    Pickering AN; Walter EL; Dawdani A; Decker A; Hamm ME; Gellad WF; Radomski TR
    BMC Geriatr; 2022 Feb; 22(1):152. PubMed ID: 35209856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing in Real Time: Hospitalized Septuagenarian With Polypharmacy.
    Famuyiro T; Montas A; Tanoos T; Obinyan TE; Raji M
    Cureus; 2023 Jun; 15(6):e40699. PubMed ID: 37485211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deprescribing medications in older people: a narrative review.
    Salahudeen MS
    Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deprescribing recommendations: An essential consideration for clinical guideline developers.
    Moriarty F; Pottie K; Dolovich L; McCarthy L; Rojas-Fernandez C; Farrell B
    Res Social Adm Pharm; 2019 Jun; 15(6):806-810. PubMed ID: 30241877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicians need to take the lead in deprescribing.
    Scott IA; Le Couteur DG
    Intern Med J; 2015 Mar; 45(3):352-6. PubMed ID: 25735580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
    Reeve E; Moriarty F; Nahas R; Turner JP; Kouladjian O'Donnell L; Hilmer SN
    Expert Opin Drug Saf; 2018 Jan; 17(1):39-49. PubMed ID: 29072544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of in-hospital deprescribing on potential prescribing omission in hospitalized elderly patients with polypharmacy.
    Kaminaga M; Komagamine J; Tatsumi S
    Sci Rep; 2021 Apr; 11(1):8898. PubMed ID: 33903645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprescribing for older adults in Australia: factors influencing GPs.
    Gillespie R; Mullan J; Harrison L
    Aust J Prim Health; 2018 Jan; 24(6):463-469. PubMed ID: 30423283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of deprescribing in the multimorbid patient.
    Cullinan S; Raae Hansen C; Byrne S; O'Mahony D; Kearney P; Sahm L
    Eur J Hosp Pharm; 2017 Jan; 24(1):43-46. PubMed ID: 31156897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deprescribing in older adults: a new concept for nurses in administering medicines and as prescribers of medicine.
    Naughton C; Hayes N
    Eur J Hosp Pharm; 2017 Jan; 24(1):47-50. PubMed ID: 31156898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.